GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 63 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $354,737 | +33.1% | 184,759 | -0.2% | 0.00% | – |
| Q2 2023 | $266,520 | -32.6% | 185,084 | -1.7% | 0.00% | – |
| Q1 2023 | $395,491 | +802.9% | 188,329 | +385.8% | 0.00% | – |
| Q4 2022 | $43,804 | -28.2% | 38,765 | +3.2% | 0.00% | – |
| Q3 2022 | $61,000 | -20.8% | 37,547 | -36.2% | 0.00% | – |
| Q2 2022 | $77,000 | -24.5% | 58,856 | -7.3% | 0.00% | – |
| Q1 2022 | $102,000 | -47.4% | 63,509 | -31.9% | 0.00% | – |
| Q4 2021 | $194,000 | -0.5% | 93,303 | +86.7% | 0.00% | – |
| Q3 2021 | $195,000 | +48.9% | 49,968 | +22.4% | 0.00% | – |
| Q2 2021 | $131,000 | +129.8% | 40,810 | +54.8% | 0.00% | – |
| Q1 2021 | $57,000 | -52.9% | 26,360 | -50.9% | 0.00% | – |
| Q4 2020 | $121,000 | +42.4% | 53,662 | +69.9% | 0.00% | – |
| Q3 2020 | $85,000 | -57.3% | 31,579 | -51.6% | 0.00% | – |
| Q2 2020 | $199,000 | +82.6% | 65,192 | +17.4% | 0.00% | – |
| Q1 2020 | $109,000 | -76.7% | 55,511 | -66.1% | 0.00% | – |
| Q4 2019 | $468,000 | +64.8% | 163,561 | +111.3% | 0.00% | – |
| Q3 2019 | $284,000 | +27.9% | 77,414 | +44.3% | 0.00% | – |
| Q2 2019 | $222,000 | -26.2% | 53,645 | -9.0% | 0.00% | – |
| Q1 2019 | $301,000 | +41.3% | 58,977 | -5.2% | 0.00% | – |
| Q4 2018 | $213,000 | -38.4% | 62,205 | +7.8% | 0.00% | – |
| Q3 2018 | $346,000 | -11.5% | 57,687 | -6.0% | 0.00% | – |
| Q2 2018 | $391,000 | +86.2% | 61,337 | +38.6% | 0.00% | – |
| Q1 2018 | $210,000 | +288.9% | 44,260 | +173.8% | 0.00% | – |
| Q4 2017 | $54,000 | -75.5% | 16,168 | -84.4% | 0.00% | – |
| Q3 2017 | $220,000 | -17.6% | 103,436 | -4.7% | 0.00% | – |
| Q2 2017 | $267,000 | -35.2% | 108,488 | -39.4% | 0.00% | – |
| Q1 2017 | $412,000 | +2842.9% | 178,966 | +1284.5% | 0.00% | – |
| Q4 2016 | $14,000 | +100.0% | 12,926 | +95.2% | 0.00% | – |
| Q3 2016 | $7,000 | -41.7% | 6,621 | -18.5% | 0.00% | – |
| Q2 2016 | $12,000 | +50.0% | 8,128 | +37.6% | 0.00% | – |
| Q1 2016 | $8,000 | -52.9% | 5,908 | -43.7% | 0.00% | – |
| Q4 2015 | $17,000 | -50.0% | 10,497 | -26.6% | 0.00% | – |
| Q3 2015 | $34,000 | -54.1% | 14,310 | -47.7% | 0.00% | – |
| Q2 2015 | $74,000 | +10.4% | 27,366 | +37.2% | 0.00% | – |
| Q1 2015 | $67,000 | -80.7% | 19,944 | -80.1% | 0.00% | – |
| Q4 2014 | $347,000 | +166.9% | 100,167 | +284.7% | 0.00% | – |
| Q3 2014 | $130,000 | -88.9% | 26,035 | -69.3% | 0.00% | – |
| Q2 2014 | $1,173,000 | -16.6% | 84,939 | -7.6% | 0.00% | -100.0% |
| Q1 2014 | $1,407,000 | +883.9% | 91,946 | +420.1% | 0.00% | – |
| Q4 2013 | $143,000 | -2.1% | 17,680 | +20.9% | 0.00% | – |
| Q3 2013 | $146,000 | – | 14,624 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 169,578 | $222,000 | 0.08% |
| Geneos Wealth Management Inc. | 478,067 | $626,000 | 0.03% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $16,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 281,700 | $369,000 | 0.01% |
| Vivaldi Capital Management LP | 17,078 | $22,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,284,481 | $1,684,000 | 0.00% |
| Ameritas Advisory Services, LLC | 45,302 | $59,000 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 20,947 | $27,000 | 0.00% |
| Summit Trail Advisors, LLC | 23,855 | $31,000 | 0.00% |
| WEDBUSH SECURITIES INC | 27,998 | $37,000 | 0.00% |